CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
Boston, Massachusetts, United States and 22 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Boston, Massachusetts, United States and 18 other locations
A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...
Boston, Massachusetts, United States and 20 other locations
The IMPACT study is a study to test a new experimental drug, IMCY-0098, for the treatment of type 1 diabetes (T1D).In most people with type ...
Phase 2
Boston, Massachusetts, United States and 28 other locations
While data from the National Health and Nutrition Examination Survey (NHANES) estimate that 36.9% of patients with diabetes have CKD, only a...
Boston, Massachusetts, United States
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Boston, Massachusetts, United States and 24 other locations
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...
Phase 3
Providence, Rhode Island, United States and 45 other locations
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Boston, Massachusetts, United States and 35 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...
Boston, Massachusetts, United States and 62 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Fall River, Massachusetts, United States and 88 other locations
Clinical trials
Research sites
Resources
Legal